Articles On Alcidion Group (ASX:ALC)

The Alcidion Group Ltd (ASX: ALC) share price is in negative territory today following the company’s latest quarterly update. During early afternoon trade, the healthcare technology company’s shares are down 4.17% to 34.5 cents. How did Al...

At the small end of the Australian share market, there are a number of companies with the potential to grow materially in the future. Three that investors may want to get better acquainted with are listed below. Here’s what you need to kno...

Alcidion Group (ALC) expands the use of its remote patient monitoring platform, Miya Precision, with the Sydney Local Health District (LHD) The contract extension will generate around an additional $1.8 million in revenue over the next thr...

It’s been a busy morning for the ASX Healthcare sector, with plenty of positive announcements for investors to digest. But the Health Index (XHJ) is trading down by 0.5% at the time of writing, compared to the broader index which is trading...

The Alcidion Group Ltd (ASX: ALC) share price is rocketing higher today after the company announced the Sydney Local Health District has expanded its use of Miya Precision. The expanded agreement will see Alcidion with an extra $1.8 millio...

Wall Street advances on strong earnings US stocks advanced on Friday on strong corporate earnings which were highlighted by record investment banking fees. Goldman Sachs’s beat analysts’ expectations and pulled in US$3.7bn in M&A adviso...

Alcidion Group (ALC) further expands the use of ExtraMed’s IPFM to Queen’s Hospital Burton in England IPFM is ExtraMed’s patient flow management software that allows frontline staff to make informed decisions based on real-time visibility...

Looking to celebrate this month with some investment treats? We asked our Foolish contributors to compile a list of some of the ASX shares experts are saying to buy in October. Tristan Harrison: Volpara Health Technologies Ltd (ASX: VHT) ...

At the small end of the Australian share market, there are a number of companies with the potential to grow materially in the future. Two that investors may want to get better acquainted with are listed below. Here’s what you need to know...

At the small end of the Australian share market, there are a number of companies with the potential to grow materially in the future. Three that investors may want to get better acquainted with are listed below. Here’s what you need to kno...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

The small end of the Australian share market is home to a number of companies with the potential to grow strongly in the future. Three small caps that investors may want to get better acquainted with are listed below. Here’s why they shoul...

Highlights Low interest rate scenario is conducive for growth stocks. The technology sector has witnessed a major tail wind since the rapid digitisation post the COVID-19 outbreak. Knosys is to acquire a leading Library Management Sof...

The Alcidion Group [ASX:ALC] reported record revenue for FY21 of $25.9 million. The record revenue was not enough to increase ALC’s shares, with the Alcidion stock currently down 1.5%. The post Alcidion Posts Record FY21 Revenue but Shares...

“We have a tremendous growth opportunity ahead of us in the new financial year as Alcidion builds on the record-breaking momentum created in FY21,” says MD.

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

If you’re wanting to invest in the small side of the Australian share market, then the three small caps listed below could be worth a closer look. All three have been tipped for big things in the future. Here’s why these small cap ASX shar...

Buy ASX shares for the long term, we’re always told. Don’t try to time the market. But the irony is the same experts that espouse this to retail investors don’t, or can’t, follow it themselves. That’s because fund managers are judged by po...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

Are you interested in small cap shares? If you are, then you may want to look at the ones listed below. Both these small cap ASX shares have been given buy ratings and are tipped for big things in the future. Here’s what you need to know:...

The ASX 200 touched intraday record highs, but could not hold on and closed the day just shy of its all time high. The benchmark index finished 0.46% higher at 7,428, and is now on track to finish July on a 10-month winning streak. Six out...

The Alcidion Group Ltd (ASX: ALC) share price is delivering gains to shareholders on Tuesday. At the time of writing, the healthcare software provider’s shares are swapping hands for 40.5 cents, up 14%. Why is the Alcidion share price surg...

Leading the ASX companies rising thanks to financial updates were a number of beneficiaries of the COVID-19 tech boom. As the week when quarterlies are due progresses and the market announcements page becomes increasingly flooded with lodge...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Ask A Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In this edition, Cyan Investment Management portfolio manager Dean Fergie tips 2 ASX shares flying under the radar...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

If you’re wanting to invest in the small side of the Australian share market, then the three small caps listed below could be worth a closer look. While there is certainly still a lot of work to be done, they could have very bright futures...

We all know the ASX as a place to trade shares in some of Australia’s largest companies, but what about small-cap stocks? The truth is that there are many small-cap shares you may not have even heard of before on the ASX. While these compa...

Summary Small-cap stocks have historically outperformed large-cap stocks. But investors must be careful while picking up these stocks owing to their volatile nature. Whispir and Alcidion are a few small-cap stocks to consider. Sma...

At the small end of the Australian share market, there are a number of companies with the potential to grow materially in the future. Four that investors might want to get better acquainted with are listed below. Here’s what you need to kn...

Shares in the Alcidion Group Ltd (ASX: ALC) share price have rocketed 20% in the last 30 days, and are up 163% in the last 12 months. At yesterday’s market close, the Alcidion share price was trading at 44 cents. Let’s look at some of the...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Are you looking to add a small cap share or two to your portfolio? If you are, then you might want to take a look at  the shares listed below. These three shares have been growing at a solid rate and could have bright futures ahead of them...

Investors will be watching for updates on Traka Resources (ASX:TKL) this week, after the gold explorer ripped higher on no news to post an RSI reading of 91. Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Re...

Having recently been beaten, battered and bruised, smaller tech shares had a well deserved day in the sun on Thursday, with the S&P/ASX All Technology Index (ASX: XTX) handily out-pacing the S&P/ASX 200 Index (ASX: XJO). Could the...

LBT Innovations (ASX:LBT) shares rose this morning after it sold its first two pathology sample analysers in the UK. LBT’s APAS Independence (Automated Plate Assessment System) sorts medical samples and uses AI and machine learning to deter...

Summary Growth stocks remains on investors’ radar due to their remarkable growth potential due to innovative technology, patents or other competitive advantage. Chalice Mining Limited has witnessed continued expansion of the Gonneville...

Australia’s digital and technology sector got a major boost in last night’s Federal Budget, with the government announcing a total of $1.2 billion spending for the whole sector. Part of that, or around 10 per cent, will be used to support t...

Philippe Bui, Medallion Financial Group BUY RECOMMENDATIONS Alcidion Group (ALC) Alcidion develops software products for the healthcare sectors in Australia, New Zealand and the UK. The company recently announced a $15 million capital raisi...

The Alcidion Group Ltd (ASX: ALC) share price has continued its negative run this week and is again backtracking today. This comes despite the company announcing the completion of its Share Purchase Plan (SSP). In mid-afternoon trade, the...

The capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the first four months of the year. Across 325 deals, ASX companies have raised $9.878 billion in capital amidst IPOs, placements and rights issues....

Alcidion Group Ltd (ASX: ALC) shares are on the slide today despite the company reporting “strong organic growth” in its March quarterly update.  At the time of writing, the Alcidion share price is trading 2.6% lower at 37.5 cents. In comp...

The Alcidion Group Ltd (ASX: ALC) share price is having quite the month, up 32.25% so far in April. Shares in the company have risen off the back of a number of positive catalysts. The Alcidion share price is showing no signs of slowing do...

Alcidion (ASX:ALC) was last week selected as a preferred provider for the Australian Department of Defence (DoD).  The company was selected as part of a consortium that will provide data capture services, as part of the Department’s healthc...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week With stock...

Source: Daniel Fung, Shutterstock Summary The ASX 200 traded lower on Friday, even as US stocks closed on a strong note overnight. The weakness in energy and financial stocks dragged down the index. Beach Energy, Monadelphous Group,...

Source:Pixels Hunter, Shutterstock Summary Alcidion Group and Netccentric Limited have drawn market participants' attention driven by their recent ASX announcements. Alcidion Group was selected as a preferred provider for the Departme...

Source: REDPIXEL.PL, Shutterstock Summary Total Brain introduced discrete & continuous HRV functionality to its existing mental health self-monitoring and self-care platform. Electrochemical strips developer Universal Biosensors I...

The Alcidion Group Ltd (ASX: ALC) share price is having a stellar day on Thursday. Today’s positive price movement comes after the company provided updates on a new acquisition, a new government contract, and a capital raising endeavour. A...

15 Apr 2021 - Healthcare informatics developer Alcidion (ASX:ALC) has ironed out terms for the proposed takeover of British health technology specialist ExtraMed.